Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Esra Demircioglu

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Nature Communications|November 7, 2022
Structure of the IscB-ωRNA ribonucleoprotein complex, the likely ancestor of CRISPR-Cas9Kazuki Kato, Sae Okazaki, Soumya Kannan, et al.
Nature|October 12, 2022
Structure of the OMEGA nickase IsrB in complex with ωRNA and target DNASeiichi Hirano, Kalli Kappel, Han Altae-Tran, et al.
Journal of Medicinal Chemistry|October 30, 2025
Discovery of Clinical Candidate GDC-8264, a Novel, Potent and Selective RIP1 Inhibitor for Amelioration of Tissue Damage and the Treatment of Inflammatory DiseasesSnahel Patel, Huifen Chen, Eugene Varfolomeev, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Nature Communications|November 7, 2022
Structure of the IscB-ωRNA ribonucleoprotein complex, the likely ancestor of CRISPR-Cas9Kazuki Kato, Sae Okazaki, Soumya Kannan, et al.
Nature|October 12, 2022
Structure of the OMEGA nickase IsrB in complex with ωRNA and target DNASeiichi Hirano, Kalli Kappel, Han Altae-Tran, et al.
Journal of Medicinal Chemistry|October 30, 2025
Discovery of Clinical Candidate GDC-8264, a Novel, Potent and Selective RIP1 Inhibitor for Amelioration of Tissue Damage and the Treatment of Inflammatory DiseasesSnahel Patel, Huifen Chen, Eugene Varfolomeev, et al.
Pageof 2